Published in World J Surg on January 01, 2007
Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res (2009) 1.70
Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression. World J Gastroenterol (2014) 0.82
Limited clinical relevance of mitochondrial DNA mutation and gene expression analyses in ovarian cancer. BMC Cancer (2008) 0.77
Sequence and organization of the human mitochondrial genome. Nature (1981) 57.39
On the origin of cancer cells. Science (1956) 49.55
Mitochondria and apoptosis. Science (1998) 23.41
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science (1988) 11.76
Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65
Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science (1999) 5.20
Mitochondrial membrane potential in living cells. Annu Rev Cell Biol (1988) 4.73
Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet (1998) 4.67
PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol (1991) 4.65
Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology (1988) 4.28
Mitochondrial myopathies. Ann Neurol (1985) 3.81
Denaturing high-performance liquid chromatography: A review. Hum Mutat (2001) 3.58
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet (1992) 3.53
Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab (1990) 3.02
A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer (1979) 2.67
Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology (2000) 2.61
mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet (1991) 2.53
The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer (1989) 2.52
Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg (1953) 2.41
Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem (1997) 2.02
Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur J Cancer (1999) 1.94
Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med (1997) 1.91
Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1986) 1.84
Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Res (1995) 1.84
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab (1997) 1.71
Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg (1997) 1.71
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer (1985) 1.66
Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol (2002) 1.61
Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg (1976) 1.61
Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene (2000) 1.58
Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA. Ultrastruct Pathol (1998) 1.52
Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies. Mol Pathol (2000) 1.48
Mitochondrial mutational spectra in human cells and tissues. Proc Natl Acad Sci U S A (1997) 1.45
Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res (2000) 1.38
Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat Res (1998) 1.34
Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer (1999) 1.29
Reactive oxygen species and the regulation of cell death by the Bcl-2 gene family. Biochim Biophys Acta (1995) 1.26
Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer (2001) 1.24
Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene (1998) 1.20
Risk factor analysis in differentiated thyroid cancer. Cancer (1979) 1.14
Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol (1987) 1.14
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery (1992) 1.10
Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch (2000) 1.09
Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab (1995) 1.08
Mitochondrial localization of APE/Ref-1 in thyroid cells. Mutat Res (2001) 1.08
Survival discriminants for differentiated thyroid cancer. Am J Surg (1990) 1.07
Influence of age and sex on incidence and prognosis of thyroid cancer. Three hundred forty-four cases followed for ten years. Cancer (1966) 1.04
Importance of lymph node metastases in follicular thyroid cancer. World J Surg (2002) 0.96
Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Cytogenet Cell Genet (1994) 0.90
Solitary, multiple, and familial oxyphil tumours of the thyroid gland. J Pathol (1998) 0.89
Comments on: mutations in mitochondrial control region DNA in gastric tumours of Japanese patients, Tamura, et al. Eur J Cancer 1999, 35, 316-319. Eur J Cancer (1999) 0.89
Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy. Surgery (1998) 0.87
Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid. J Pathol (2000) 0.86
Incidence of thyroid cancer in Norway 1970-1985. Population review on time trend, sex, age, histological type and tumour stage in 2625 cases. APMIS (1990) 0.86
Mechanisms of Bcl-2 protein function. Histol Histopathol (1998) 0.85
The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastruct Pathol (1998) 0.85
Mitochondrial genes and disease. Hosp Pract (Off Ed) (1986) 0.85
Aging research. Do mitochondrial mutations dim the fire of life? Science (1999) 0.83
Functional and molecular analysis of mitochondria in thyroid oncocytoma. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.82
Prognostic features of thyroid cancer. A long-term followup of 68 cases. Cancer (1975) 0.80
An electron-microscopic study of human thyroid cancer. Endocrinologie (1980) 0.79
Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol (1988) 0.79
Modulation of gene expression as a biomarker in colon. J Cell Biochem Suppl (1992) 0.78
[Prognostically relevant factors in follicular thyroid cancer]. Langenbecks Arch Chir (1990) 0.75
[Polymerase chain reaction: an overview]. Naturwissenschaften (1990) 0.75
[The significance of lymph node status in papillary and follicular thyroid gland carcinoma for the nuclear medicine physician]. Zentralbl Chir (2000) 0.75
Long-term clinical and biochemical follow-up in medullary thyroid carcinoma: a single institution's experience over 20 years. Ann Surg (2007) 1.62
Adrenal involvement in multiple endocrine neoplasia type 1. World J Surg (2002) 1.13
Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res (2004) 0.99
Importance of lymph node metastases in follicular thyroid cancer. World J Surg (2002) 0.96
Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes. Exp Hematol (2011) 0.85
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood (2003) 0.81
Human bocavirus is not detectable in bone marrow from patients with myelodysplastic syndromes. Influenza Other Respir Viruses (2011) 0.75
Development of demand forecasting tool for natural resources recouping from municipal solid waste. Waste Manag Res (2013) 0.75
Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study. Hematol Oncol (2008) 0.75